Načítá se...
Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
BACKGROUND: Carmustine (BCNU) wafers (Gliadel) prolongs local disease control and progression-free survival (PFS) in patients with malignant gliomas. However, in metastatic brain tumors, there is a paucity of evidence in support of its safety and efficacy. The goal of this study was to assess the sa...
Uloženo v:
| Vydáno v: | Surg Neurol Int |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4866053/ https://ncbi.nlm.nih.gov/pubmed/27217968 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2152-7806.181987 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|